A Study of Meditation as a Treatment for Epilepsy

Epilepsy Clinical Trial

Official title:

Treatment of Epilepsy by Meditation and Cultivation of Emotional Balance

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00370929
• Other study ID #: HSPC-06-03-001
• Status: Completed
• Phase: N/A
• First received: August 30, 2006
• Last updated: July 20, 2016
• Start date: May 2006
• Est. completion date: January 2008

Study information

• Verified date: July 2016
• Source: University of California, Los Angeles
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Epileptic seizures may occur at times of stress and commonly increase life stress. This study will evaluate whether meditation improves seizure control and quality of life for individuals with uncontrolled epilepsy.

Description:

Individuals who have uncontrolled epilepsy commonly experience disability, depression, anxiety and injuries from seizures. For such individuals, ideal treatments should improve quality of life through control of seizures and improved emotional state. Meditation with cultivation of emotional balance is known to improve emotional state and may also benefit seizure control in some individuals. In this study, individuals with uncontrolled epilepsy will receive detailed training in meditation to determine whether the training leads to improvements in seizure control and various measures of emotion and quality of life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8
• Est. completion date: January 2008
• Est. primary completion date: January 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 6 or more seizures per month

• ability to participate in meditation

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Epilepsy

Intervention

Behavioral:
• Meditation

Locations

Country	Name	City	State
United States	Geffen School of Medicine at UCLA	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Seizure frequency		20 weeks	No
Primary	Quality of Life		20 weeks	No
Secondary	Mood		20 weeks	No
Secondary	Affect		20 weeks	No
Secondary	Anxiety		20 weeks	No
Secondary	Sleep quality		20 weeks	No